Home › DiaSorin Receives CE Mark for Simplexa Group B Strep Assay

DiaSorin Receives CE Mark for Simplexa Group B Strep Assay

Oct 18, 2018

This article has been updated from a previous version to correct the technology used in the Meridian H. Pylori assay.

NEW YORK (GenomeWeb) – DiaSorin Molecular said today that it has received CE marking for its Simplexa Group B Strep Direct assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

  2. Point-of-Care Molecular Diagnostic Platform That Skips Need for Amplification Being Developed at UCLA

    Premium

  3. Natera Waits for ACOG Guidance on Average-Risk NIPT; Pushes Ahead in Oncology, Transplantation

    Premium

  4. Guardant Health, Core Diagnostics Team Up to Offer Liquid Biopsy in India

  5. Health Canada Approves Two BCR-ABL Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.